Search





Search





Markets
/
Stocks
/
rcus
/

Arcus Biosciences Inc

RCUS

Add to Watchlist

28.190USD

-0.040-0.14%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.55BMarket Cap

LossP/E TTM

Arcus Biosciences Inc

28.190

-0.040-0.14%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

RCUS Cash Flow Statement

You can access the annual and quarterly cash flow statements of Arcus Biosciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-4.55%-138.00M

-20.00%-120.00M

-473.08%-97.00M

-41.49%-133.00M

-6500.00%-132.00M

-13.64%-100.00M

141.27%26.00M

-64.91%-94.00M

97.96%-2.00M

-26.18%-88.00M

22.18%-63.00M

12.71%-57.00M

-114.98%-98.00M

-12.30%-69.74M

-50.60%-80.96M

11.75%-65.30M

1086.19%654.00M

-24.50%-62.10M

-124.86%-53.76M

-209.11%-74.00M

-112.03%-66.32M

-426.66%-49.88M

889.32%216.26M

-21.19%-23.94M

-85.74%-31.28M

-33.26%-9.47M

-132.89%-27.40M

-81.60%-19.75M

-27.12%-16.84M

-145.60%-7.11M

51.45%-11.77M

-59.60%-10.88M

-38.03%-13.25M

--15.59M

---24.23M

---6.81M

---9.60M

Net income from continuing operations

-14.29%-128.00M

-12.77%-106.00M

-46.74%-135.00M

100.00%0.00

-2700.00%-112.00M

-16.05%-94.00M

-29.58%-92.00M

-24.00%-93.00M

95.00%-4.00M

-20.08%-81.00M

-9.37%-71.00M

-12.56%-75.00M

-17.66%-80.00M

-124.15%-67.46M

16.74%-64.92M

12.29%-66.63M

6.34%-67.99M

638.77%279.37M

-4379.64%-77.97M

-68.55%-75.97M

-161.57%-72.59M

-212.41%-51.85M

108.15%1.82M

-60.46%-45.07M

-57.06%-27.75M

-35.00%-16.60M

-106.75%-22.35M

-107.55%-28.09M

-36.41%-17.67M

6.93%-12.29M

53.24%-10.81M

-41.72%-13.53M

-79.92%-12.95M

---13.21M

---23.12M

---9.55M

---7.20M

Operating gains losses

-33.33%2.00M

0.00%3.00M

0.00%2.00M

-86.96%3.00M

0.00%3.00M

100.00%2.00M

0.00%2.00M

1050.00%23.00M

102.98%3.00M

-35.90%1.00M

32.89%2.00M

37.27%2.00M

17.30%1.48M

61.99%1.56M

83.54%1.50M

82.13%1.46M

61.95%1.26M

29.78%963.00K

4.19%820.00K

-4.99%800.00K

-9.11%778.00K

-16.25%742.00K

-10.87%787.00K

-11.65%842.00K

-9.61%856.00K

-9.03%886.00K

-3.50%883.00K

15.10%953.00K

23.63%947.00K

33.06%974.00K

45.70%915.00K

70.37%828.00K

--766.00K

--732.00K

--628.00K

--486.00K

Other non-cash items

100.00%0.00

33.33%-2.00M

125.00%1.00M

50.00%-2.00M

25.00%-3.00M

-100.00%-4.00M

-300.00%-4.00M

-1687.30%-4.00M

-307.04%-2.00M

-161.63%-2.00M

-115.30%-1.00M

-93.26%252.00K

-51.11%966.00K

118.52%3.25M

526.15%6.54M

181.49%3.74M

19860.00%1.98M

2080.00%1.48M

520.97%1.04M

412.71%1.33M

98.42%-10.00K

91.00%-75.00K

66.80%-248.00K

42.18%-425.00K

37.76%-633.00K

-605.93%-833.00K

-1166.10%-747.00K

-606.73%-735.00K

-4321.74%-1.02M

-413.04%-118.00K

-96.67%-59.00K

---104.00K

---23.00K

---30.00K

Change in working capital

16.22%-31.00M

-30.43%-30.00M

-79.21%21.00M

-678.95%-148.00M

0.00%-37.00M

4.17%-23.00M

1222.22%101.00M

---19.00M

2.63%-37.00M

-16.87%-24.00M

74.16%-9.00M

100.00%0.00

-105.45%-38.00M

94.30%-20.54M

-620.26%-34.83M

-39.43%-19.10M

8474.87%697.46M

-4389.56%-360.29M

-96.78%6.69M

-185.85%-13.70M

-9.87%-8.33M

-288.42%-8.03M

2573.32%207.71M

177.75%15.95M

-412.16%-7.58M

18.34%4.26M

-291.52%-8.40M

215.26%5.74M

23.87%-1.48M

-87.07%3.60M

-3.27%-2.15M

-5.50%1.82M

35.09%-1.94M

--27.82M

---2.08M

--1.93M

---3.00M

-Change in receivables

60.00%8.00M

100.00%0.00

-66.67%4.00M

-100.00%0.00

-61.54%5.00M

---4.00M

9.09%12.00M

450.00%7.00M

116.67%13.00M

100.00%0.00

56.14%11.00M

68.81%-2.00M

-99.16%6.00M

31.44%-11.81M

900.71%7.04M

-275.19%-6.41M

17184.95%715.18M

-1225.75%-17.22M

129.87%704.00K

2900.00%3.66M

-1874.53%-4.19M

-70.26%1.53M

54.79%-2.36M

296.77%122.00K

-355.42%-212.00K

2.25%5.14M

-5.95%-5.21M

55.40%-62.00K

386.21%83.00K

-79.88%5.03M

80.26%-4.92M

-561.90%-139.00K

-107.16%-29.00K

--25.01M

---24.93M

---21.00K

--405.00K

-Change in prepaid expenses

----

429.05%2.15M

-262.80%-6.18M

312.88%9.62M

-22.37%-5.59M

-109.28%-654.00K

215.59%3.80M

-403.68%-4.52M

-23.33%-4.57M

8908.75%7.05M

-245.68%-3.28M

-364.77%-897.00K

-388.01%-3.70M

-1100.00%-80.00K

-21.95%-950.00K

-167.96%-193.00K

-9.52%-759.00K

-98.51%8.00K

15.51%-779.00K

205.19%284.00K

-621.88%-693.00K

--537.00K

---922.00K

---270.00K

---96.00K

-Change in other current assets

---3.00M

-100.00%0.00

500.00%6.00M

-110.00%-1.00M

-100.00%0.00

400.00%6.00M

109.09%1.00M

42.86%10.00M

162.50%5.00M

-155.01%-2.00M

-5570.10%-11.00M

2356.14%7.00M

-363.23%-8.00M

41.37%3.64M

-169.53%-194.00K

-30.15%285.00K

-2841.27%-1.73M

164.28%2.57M

122.54%279.00K

1027.27%408.00K

169.23%63.00K

-556.98%-4.00M

-2310.71%-1.24M

-780.00%-44.00K

-203.33%-91.00K

-661.25%-609.00K

--56.00K

---5.00K

---30.00K

-1233.33%-80.00K

----

---6.00K

----

-Change in other current liabilities

26.67%-33.00M

0.00%-30.00M

-102.25%-2.00M

-330.56%-155.00M

16.67%-45.00M

-25.00%-30.00M

693.33%89.00M

-357.14%-36.00M

-17.39%-54.00M

-46.62%-24.00M

53.86%-15.00M

153.06%14.00M

-192.34%-46.00M

95.19%-16.37M

-243.64%-32.51M

-178.87%-26.38M

-66.28%-15.73M

-3336.74%-340.00M

-104.69%-9.46M

-499.94%-9.46M

-403.62%-9.46M

-427.35%-9.89M

6355.53%201.93M

15.67%-1.58M

-0.86%-1.88M

-11.93%-1.88M

-13.16%3.13M

-35.70%-1.87M

-40.50%-1.86M

-130.54%-1.68M

-85.41%3.60M

-800.65%-1.38M

-827.27%-1.33M

---727.00K

--24.68M

---153.00K

---143.00K

Cash from non-recurring investing activities

Cash from operating activities

-4.55%-138.00M

-20.00%-120.00M

-473.08%-97.00M

-41.49%-133.00M

-6500.00%-132.00M

-13.64%-100.00M

141.27%26.00M

-64.91%-94.00M

97.96%-2.00M

-26.18%-88.00M

22.18%-63.00M

12.71%-57.00M

-114.98%-98.00M

-12.30%-69.74M

-50.60%-80.96M

11.75%-65.30M

1086.19%654.00M

-24.50%-62.10M

-124.86%-53.76M

-209.11%-74.00M

-112.03%-66.32M

-426.66%-49.88M

889.32%216.26M

-21.19%-23.94M

-85.74%-31.28M

-33.26%-9.47M

-132.89%-27.40M

-81.60%-19.75M

-27.12%-16.84M

-145.60%-7.11M

51.45%-11.77M

-59.60%-10.88M

-38.03%-13.25M

--15.59M

---24.23M

---6.81M

---9.60M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

0.00%1.00M

-100.00%0.00

--0.00

-75.00%1.00M

-83.33%1.00M

-90.00%1.00M

-100.00%0.00

33.33%4.00M

1478.95%6.00M

658.73%10.00M

230.25%5.00M

7.60%3.00M

-95.53%380.00K

-83.23%1.32M

-75.07%1.51M

-23.43%2.79M

459.97%8.51M

633.71%7.86M

2272.27%6.07M

1642.11%3.64M

675.00%1.52M

94.73%1.07M

-53.54%256.00K

-66.72%209.00K

-24.03%196.00K

-51.20%550.00K

-57.75%551.00K

-40.42%628.00K

-12.24%258.00K

34.33%1.13M

-41.84%1.30M

-50.72%1.05M

--294.00K

--839.00K

--2.24M

--2.14M

Capital expenditures

-100.00%0.00

0.00%1.00M

-100.00%0.00

--0.00

-75.00%1.00M

-83.33%1.00M

-90.00%1.00M

-100.00%0.00

33.33%4.00M

1478.95%6.00M

658.73%10.00M

230.25%5.00M

7.60%3.00M

-95.53%380.00K

-83.23%1.32M

-75.07%1.51M

-23.43%2.79M

459.97%8.51M

633.71%7.86M

2272.27%6.07M

1642.11%3.64M

675.00%1.52M

94.73%1.07M

-53.54%256.00K

-66.72%209.00K

-24.03%196.00K

-51.20%550.00K

-57.75%551.00K

-40.42%628.00K

-12.24%258.00K

34.33%1.13M

-41.84%1.30M

-50.72%1.05M

--294.00K

--839.00K

--2.24M

--2.14M

Net cash flow from disposal of fixed assets

-100.00%0.00

0.00%1.00M

-100.00%0.00

--0.00

-75.00%1.00M

-83.33%1.00M

-90.00%1.00M

-100.00%0.00

33.33%4.00M

1478.95%6.00M

658.73%10.00M

230.25%5.00M

7.60%3.00M

-95.53%380.00K

-83.23%1.32M

-75.07%1.51M

-23.43%2.79M

459.97%8.51M

633.71%7.86M

2272.27%6.07M

1642.11%3.64M

675.00%1.52M

94.73%1.07M

-53.54%256.00K

-66.72%209.00K

-24.03%196.00K

-51.20%550.00K

-57.75%551.00K

-40.42%628.00K

-12.24%258.00K

34.33%1.13M

-41.84%1.30M

-50.72%1.05M

--294.00K

--839.00K

--2.24M

--2.14M

Net cash flow from investment products

245.45%114.00M

-448.08%-181.00M

382.14%79.00M

117.46%137.00M

120.00%33.00M

52.94%52.00M

-233.33%-28.00M

103.23%63.00M

-225.00%-165.00M

-28.33%34.00M

-4.61%21.00M

114.89%31.00M

149.76%132.00M

73.02%47.44M

127.26%22.01M

-2393.77%-208.18M

-499.10%-265.27M

2028.88%27.42M

79.08%-80.75M

110.45%9.08M

65.07%66.47M

110.82%1.29M

-1348.78%-386.05M

-418.90%-86.82M

170.11%40.27M

-530.05%-11.91M

137.60%30.91M

283.71%27.22M

196.57%14.91M

106.63%2.77M

-705.82%-82.21M

-1380.42%-14.82M

-7.54%-15.44M

---41.77M

--13.57M

---1.00M

---14.35M

Net cash flow from other investing activities

----

--0.00

----

100.00%0.00

----

---250.00K

--2.75M

---5.50M

----

Cash from non-current investing activities

Net cash flow from investing activities

256.25%114.00M

-456.86%-182.00M

372.41%79.00M

117.46%137.00M

118.93%32.00M

82.14%51.00M

-363.64%-29.00M

142.31%63.00M

-231.01%-169.00M

-40.18%28.00M

-53.08%11.00M

112.08%26.00M

148.12%129.00M

147.49%46.81M

126.46%23.45M

-7266.07%-215.20M

-526.67%-268.06M

8287.88%18.91M

77.11%-88.61M

103.45%3.00M

56.85%62.83M

98.09%-231.00K

-1374.93%-387.12M

-426.45%-87.07M

180.52%40.06M

-582.04%-12.10M

136.44%30.36M

265.43%26.67M

186.59%14.28M

105.97%2.51M

-754.60%-83.34M

-397.16%-16.12M

0.01%-16.49M

---42.07M

--12.73M

---3.24M

---16.49M

Financing cash flow

Cash flow from continuous financing activities

-97.89%3.00M

14400.00%286.00M

-83.33%8.00M

2500.00%52.00M

-37.99%142.00M

-166.67%-2.00M

700.00%48.00M

-91.30%2.00M

22800.00%229.00M

-73.20%3.00M

137.06%6.00M

429.22%23.00M

-93.30%1.00M

-4.08%11.20M

92.03%2.53M

94.80%4.35M

-93.28%14.93M

595.95%11.67M

-98.77%1.32M

-99.32%2.23M

36313.11%222.12M

222.50%1.68M

262339.02%107.52M

50573.34%328.87M

12300.00%610.00K

-32.56%520.00K

-485.71%-41.00K

158.05%649.00K

-100.00%-5.00K

-99.28%771.00K

-103.70%-7.00K

-293.09%-1.12M

446203.45%129.43M

--106.60M

--189.00K

--579.00K

--29.00K

Net cash flow from debt Issuance/repayment

----

--0.00

-100.00%0.00

--49.00M

----

--0.00

--47.00M

----

Net cash flow from common stock issuance/repurchase

-97.89%3.00M

9433.33%286.00M

300.00%8.00M

0.00%3.00M

-37.99%142.00M

0.00%3.00M

-66.67%2.00M

-86.96%3.00M

22800.00%229.00M

-51.57%3.00M

137.06%6.00M

429.22%23.00M

-89.93%1.00M

-7.14%6.20M

92.03%2.53M

94.80%4.35M

-95.53%9.93M

297.79%6.67M

-98.77%1.32M

-99.32%2.23M

36313.11%222.12M

173.13%1.68M

262339.02%107.52M

50573.34%328.87M

12300.00%610.00K

-20.36%614.00K

-925.00%-41.00K

2303.70%649.00K

-100.00%-5.00K

711.58%771.00K

-102.12%-4.00K

-95.34%27.00K

446668.97%129.56M

--95.00K

--189.00K

--579.00K

--29.00K

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

----

--106.50M

----

Proceeds from stock option exercised by employees

----

---94.00K

----

Net cash flow from other financing activities

----

100.00%0.00

----

---5.00M

---1.00M

----

-100.00%0.00

--0.00

-100.00%0.00

0.00%5.00M

--0.00

--5.00M

----

--0.00

100.00%0.00

--0.00

---3.00K

---1.15M

---135.00K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-97.89%3.00M

14400.00%286.00M

-83.33%8.00M

2500.00%52.00M

-37.99%142.00M

-166.67%-2.00M

700.00%48.00M

-91.30%2.00M

22800.00%229.00M

-73.20%3.00M

137.06%6.00M

429.22%23.00M

-93.30%1.00M

-4.08%11.20M

92.03%2.53M

94.80%4.35M

-93.28%14.93M

595.95%11.67M

-98.77%1.32M

-99.32%2.23M

36313.11%222.12M

222.50%1.68M

262339.02%107.52M

50573.34%328.87M

12300.00%610.00K

-32.56%520.00K

-485.71%-41.00K

158.05%649.00K

-100.00%-5.00K

-99.28%771.00K

-103.70%-7.00K

-293.09%-1.12M

446203.45%129.43M

--106.60M

--189.00K

--579.00K

--29.00K

Net cash flow

Beginning cash balance

47.06%225.00M

18.14%241.00M

57.86%251.00M

3.72%195.00M

17.69%153.00M

9.09%204.00M

-31.76%159.00M

-21.99%188.00M

-37.80%130.00M

-15.28%187.00M

-15.47%233.00M

-56.32%241.00M

38.48%209.00M

20.99%220.73M

-14.79%275.63M

40.67%551.79M

-13.07%150.92M

-17.84%182.44M

13.35%323.49M

480.86%392.25M

198.62%173.62M

180.39%222.05M

274.18%285.39M

-1.71%67.53M

-18.42%58.14M

5.75%79.19M

-55.13%76.27M

-65.32%68.70M

-27.59%71.27M

309.10%74.89M

473.93%170.00M

406.70%198.12M

51.05%98.43M

--18.31M

--29.62M

--39.10M

--65.16M

Current period cash flow changes

-150.00%-21.00M

68.63%-16.00M

-122.22%-10.00M

293.10%56.00M

-27.59%42.00M

10.53%-51.00M

197.83%45.00M

-262.50%-29.00M

81.25%58.00M

-385.81%-57.00M

16.34%-46.00M

97.10%-8.00M

-92.02%32.00M

62.77%-11.73M

61.02%-54.98M

-301.61%-276.15M

83.35%400.87M

34.93%-31.52M

-122.70%-141.05M

-131.56%-68.76M

2228.58%218.63M

-130.04%-48.43M

-2266.07%-63.34M

2778.31%217.86M

466.04%9.39M

-450.46%-21.05M

103.07%2.92M

126.92%7.57M

-102.57%-2.56M

-104.77%-3.83M

-740.63%-95.11M

-196.63%-28.12M

482.53%99.69M

--80.12M

---11.31M

---9.48M

---26.06M

Ending cash balance

4.62%204.00M

47.06%225.00M

18.14%241.00M

57.86%251.00M

3.72%195.00M

17.69%153.00M

9.09%204.00M

-31.76%159.00M

-21.99%188.00M

-37.80%130.00M

-15.25%187.00M

-15.47%233.00M

-56.32%241.00M

38.48%209.00M

20.95%220.65M

-14.79%275.63M

40.67%551.79M

-13.07%150.92M

-17.84%182.44M

13.35%323.49M

480.86%392.25M

198.62%173.62M

180.39%222.05M

274.18%285.39M

-1.71%67.53M

-18.19%58.14M

5.75%79.19M

-55.13%76.27M

-65.32%68.70M

-27.80%71.06M

309.10%74.89M

473.93%170.00M

406.70%198.12M

--98.43M

--18.31M

--29.62M

--39.10M

Free cash flow

-3.76%-138.00M

-19.80%-121.00M

-488.00%-97.00M

-41.49%-133.00M

-2116.67%-133.00M

-7.45%-101.00M

134.25%25.00M

-51.61%-94.00M

94.06%-6.00M

-34.06%-94.00M

11.28%-73.00M

7.21%-62.00M

-115.51%-101.00M

0.69%-70.12M

-33.53%-82.28M

16.55%-66.82M

1030.88%651.21M

-37.37%-70.61M

-128.63%-61.62M

-230.94%-80.07M

-122.18%-69.96M

-431.70%-51.40M

869.95%215.19M

-19.16%-24.19M

-80.26%-31.49M

-31.26%-9.67M

-116.79%-27.95M

-66.69%-20.30M

-22.14%-17.47M

-148.16%-7.37M

48.58%-12.89M

-34.49%-12.18M

-21.86%-14.30M

--15.29M

---25.07M

---9.06M

---11.74M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Arcus Biosciences Inc Generate?



Arcus Biosciences Inc generated -482.00M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Arcus Biosciences Inc's Operating Cash Flow Change Year Over Year?



Arcus Biosciences Inc's operating cash flow increased by -183.53% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Arcus Biosciences Inc Spend on Capital Expenditures?



Arcus Biosciences Inc spent 2.00M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Arcus Biosciences Inc's Financing Cash Flow Changed?



Arcus Biosciences Inc used 488.00M in financing activities in the latest quarter.

What is free cash flow and why does it matter for RCUS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Arcus Biosciences Inc’s free cash flow in the latest quarter?



Free cash flow was -484.00M reflecting a -175.00% change from the previous year.